Related Experiment Videos
C-erbB2, p27 and G1/S aberrations in human primary breast cancer
Martin Lodén1, Frans Perris, Niels Hilmer Nielsen
1Department of Pathology, Umea University, S-901 87 Umea, Sweden.
Background:
C-erbB2 is overexpressed in approximately one-fourth of human breast cancers. In spite of numerous reports suggesting a connection of c-erbB2 overexpression with cell cycle regulation through p27, D cyclins and c-myc, the relationship between c-erbB2 and proliferation through de-regulation of the pRb pathway in primary breast cancer has not been fully clarified.
Materials And Methods:
For this purpose we compared the expression of c-erbB2 in a total of 105 primary breast tumours with a variety of cell cycle proteins and clinical parameters.
Results:
C-erbB2 was strongly correlated with down-regulation of p27 and overexpression of c-erbB2 was, as expected, associated with poor survival. However, there was no correlation with proliferation. There was, nevertheless, an association between c-erbB2 and proliferation in certain subtypes of breast cancer, as in oestrogen-receptor-positive tumours, tumours with high cyclin D1, and in tumours with an overall linear pRb pathway, i.e. tumours with a preserved linearity between cyclin D1, pRb phosphorylation and proliferation.
Conclusion:
Our results suggest that c-erbB2 may have alternative functions in different subtypes of breast cancer, and further stress that c-erbB2, in addition to promoting proliferation, also functions through other mechanisms in breast cancer.
Insights
C-erbB2 overexpression in breast cancer is linked to poor survival and cell cycle changes. However, its direct role in proliferation varies by tumor subtype, suggesting diverse functions.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- C-erbB2 (human epidermal growth factor receptor 2) overexpression occurs in ~25% of breast cancers.
- While linked to cell cycle regulators like p27, D cyclins, and c-myc, the precise relationship between C-erbB2 and proliferation via the pRb pathway in primary breast cancer remains unclear.
Purpose of the Study:
- To investigate the relationship between C-erbB2 expression and cell cycle proteins, including the pRb pathway.
- To determine the association between C-erbB2 and proliferation in primary breast tumors.
Main Methods:
- Expression analysis of C-erbB2 and various cell cycle proteins in 105 primary breast tumors.
- Correlation of C-erbB2 expression with clinical parameters and proliferation markers.
Main Results:
- C-erbB2 overexpression correlated with p27 downregulation and poorer survival.
- No overall correlation was found between C-erbB2 and proliferation.
- An association between C-erbB2 and proliferation was observed in specific subtypes: estrogen-receptor-positive tumors, those with high cyclin D1, and those with a linear pRb pathway.
Conclusions:
- C-erbB2 may exert alternative functions in different breast cancer subtypes.
- Beyond promoting proliferation, C-erbB2 likely influences breast cancer progression through additional mechanisms.